B
인터로조
119610KOSDAQ의료용 기기 제조업56.8 / 100
Reference Date: 2026-06-10
Financial Score18.5 / 40
News Sentiment21.3 / 25
Momentum5.0 / 20
Disclosure12.0 / 15
AI Analysis: PER is significantly undervalued vs. peers but the high debt ratio poses financial risk. Plunged 17.5% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Interlojo is a specialized manufacturer and seller of contact lenses, focusing on its domestic brand Clalen and OEM/ODM sales overseas. Its products are categorized by color, wearing schedule, and material, with an emphasis on expanding silicone-based premium and functional lenses.
Number of Employees
735people
Average Salary
41.6M KRW
Score Calculation Basis
Detailed Financial Score
PER
17.29Industry Average 21.515.0Point
In line with industry avg
PBR
1.27Industry Average 1.384.0Point
In line with industry avg
ROE
7.91Industry Average 8.002.5Point
Below industry avg
Debt Ratio
19.77Industry Average 11.650.5Point
1.7x industry avg (risky)
Trend 2023~20256.5 / 10 points
Revenue Growth Rate
0.5 / 3
Avg ▼1.3% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲83.4% (2-year basis)
ROE Trend
3.0 / 4
Avg ROE 5.2% (improving, 3yr)
Detailed News Sentiment
2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85
- Positive인터로조, 실리콘 하이드로겔 렌즈로 FDA 승인… 글로벌 시장 진출 본...
인터로조의 실리콘 하이드로겔 렌즈 FDA 승인으로 글로벌 시장 진출 기회 확대.
- Positive인터로조, 실리콘 하이드로겔 렌즈 美 FDA 승인 획득
인터로조의 실리콘 하이드로겔 렌즈가 미국 FDA 승인을 받아 글로벌 시장 진출이 가속화되어 긍정적인 성장 전망을 제시합니다.
Detailed Momentum
52-week position3.0Point
52w lower range (32%)
Current 17,410Won52-week high 22,55052-week low 14,950
1-month return0.0Point
1m -17.49% (strong drop)
Volume trend2.0Point
Volume decreasing
Detailed Disclosure
5 totalPositive 1Neutral 4Negative 0
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-05
- Neutral신탁계약해지결과보고서2026-05-26
- Positive주요사항보고서(자기주식취득신탁계약해지결정)2026-05-22
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-20
- Neutral분기보고서 (2026.03)2026-05-15